Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana

• Main Authors: Kathleen M. Powis (Author), Shahin Lockman (Author), Gbolahan Ajibola (Author), Michael D. Hughes (Author), Kara Bennett (Author), Jean Leidner (Author), Oganne Batlang (Author), Kerapetse Botebele (Author), Sikhulile Moyo (Author), Erik van Widenfelt (Author), Joseph Makhema (Author), Chipo Petlo (Author), Haruna B. Jibril (Author), Kenneth McIntosh (Author), Max Essex (Author), Roger L. Shapiro (Author)
• Format: Book
• Published: AOSIS, 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The World Health Organization HIV guidelines recommend either infant zidovudine (ZDV) or nevirapine (NVP) prophylaxis for the prevention of intrapartum motherto-child HIV transmission (MTCT) among formula-fed infants. No study has evaluated the comparative efficacy of infant prophylaxis...